Cargando…

Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis

Class I histone deacetylases (HDACs) inhibit expression of tumor suppressor genes by removing acetyl groups from histone lysine residues, thereby increasing cancer cell survival and proliferation. We evaluated the expression of class I HDACs in cholangiocarcinoma (CCA). HDAC3 expression was specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mingming, Yin, Yuyao, Dorfman, Robert G., Zou, Tianhui, Pan, Yida, Li, Yang, Wang, Yuming, Zhou, Qian, Zhou, Lixing, Kong, Bo, Friess, Helmut, Zhang, Jun, Zhao, Shimin, Wang, Lei, Zou, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725102/ https://www.ncbi.nlm.nih.gov/pubmed/29245911 http://dx.doi.org/10.18632/oncotarget.19660

Ejemplares similares

Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
por: Zhang, Mingming, et al.
Publicado: (2019)

Correction to: Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
por: Zhang, Mingming, et al.
Publicado: (2019)

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)

Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
por: Yin, Yuyao, et al.
Publicado: (2017)

SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism()()
por: Li, Yang, et al.
Publicado: (2018)

SIRT3 elicited an anti‐Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis
por: Xu, Lei, et al.
Publicado: (2019)

AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition
por: Zhang, Mingming, et al.
Publicado: (2016)

Downregulation of SIRT2 Inhibits Invasion of Hepatocellular Carcinoma by Inhibiting Energy Metabolism()
por: Huang, Shan, et al.
Publicado: (2017)

Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
por: Zhang, Mingming, et al.
Publicado: (2017)

Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in Cholangiocarcinoma
por: Ding, Xiwei, et al.
Publicado: (2020)

PKA cuts down on HDAC4 signaling
por: Short, Ben
Publicado: (2011)

Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis
por: Li, Song, et al.
Publicado: (2011)

Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma
por: Xiao, Yuyao, et al.
Publicado: (2023)

Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
por: Li, Yongpan, et al.
Publicado: (2022)

CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263
por: Huang, Tianlu, et al.
Publicado: (2019)

GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration
por: Zhou, Jun, et al.
Publicado: (2021)

Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1
por: Ding, Xiwei, et al.
Publicado: (2014)

YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor
por: Dong, Sheng, et al.
Publicado: (2017)

Decitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts
por: WANG, BING, et al.
Publicado: (2014)

Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion
por: Jing, Xu, et al.
Publicado: (2020)

Hydroxychloroquine Induces Apoptosis in Cholangiocarcinoma via Reactive Oxygen Species Accumulation Induced by Autophagy Inhibition
por: Chen, Jiaqi, et al.
Publicado: (2021)

HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts
por: Warnon, Céline, et al.
Publicado: (2021)

HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
por: Lin, Ching-Ling, et al.
Publicado: (2019)

HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin
por: Sun, Jun, et al.
Publicado: (2019)

Diosgenin Suppresses Cholangiocarcinoma Cells Via Inducing Cell Cycle Arrest And Mitochondria-Mediated Apoptosis
por: Mao, Xiao-Mei, et al.
Publicado: (2019)

TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors
por: He, Jun-chuang, et al.
Publicado: (2016)

Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis
por: Zhang, Fanglin, et al.
Publicado: (2011)

SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study
por: Liu, Jingshu, et al.
Publicado: (2021)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
por: Tomooka, Fumimasa, et al.
Publicado: (2023)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT
por: Zheng, Yan-Wen, et al.
Publicado: (2021)

Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3
por: Zhang, Jinduo, et al.
Publicado: (2018)

The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation
por: Chuang, Mei-Jen, et al.
Publicado: (2013)

Overexpression of Hdac6 extends reproductive lifespan in mice
por: Zhang, Xiaoxi, et al.
Publicado: (2017)

Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report
por: Wang, Jun, et al.
Publicado: (2019)

Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment
por: Zhou, Yue, et al.
Publicado: (2022)

miR-101-3p improves neuronal morphology and attenuates neuronal apoptosis in ischemic stroke in young mice by downregulating HDAC9
por: Zhang, Mengru, et al.
Publicado: (2023)

TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4
por: Wang, Huiling, et al.
Publicado: (2015)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Promotes Hepatic Stellate Cells Migration via Canonical NF-κB/MMP9 Pathway
por: Xu, Mingcui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kq4jo02cl69p616larmebnntu7